QNTM
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
QNTM
14 hedge funds and large institutions have $449K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
18% less capital invested
Capital invested by funds: $549K → $449K (-$99.4K)
Holders
14
Holding in Top 10
–
Calls
$20K
Puts
$1K
Top Buyers
| 1 | +$55.5K | |
| 2 | +$31.9K | |
| 3 | +$24.3K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$12.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.28K |
Top Sellers
| 1 | -$48.1K | |
| 2 | -$20.7K | |
| 3 | -$18K | |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$13K |
| 5 |
HF
HRT Financial
New York
|
-$13K |